Twitter Archives - PharmaLive

“What Elon Musk’s Twitter Takeover Could Mean for Advertisers”

Acquisitions, Advertisements, Business, Chatbots, Elon Musk, Healthcare Communications Agencies, Influencer Marketing, Marketing & Advertising, Social media, Speech, Twitter

Elon Musk struck a deal to buy Twitter for $44 billion. Although a somewhat unconventional character, sleeping at the Tesla headquarters and eschewing wealthy materialism, make no mistake that Musk’s successful track record in business shows how significant Twitter may become under his leadership. While no one knows for sure what will be, Casey Ross – Social Media Strategy Director at FCB Health New York – looks at some of the issues Musk has publicly called out, and their potential implications for advertisers.

April 29, 2022/by Andrew Humphreys

Med Ad News: 40 years and we’re still going

Coronavirus Disease (COVID-19) Pandemic, DTC, FDA, February 2022, Healthcare Communications Agencies, Issue Archives, Manny Awards, Marketing & Advertising, Med Ad News, Social media, TV Commercials, Twitter

1982 marked much more than pop music and classic movies. That year, Karl and Styli Engel kicked off a newsletter aimed at a particular audience: advertising agencies serving healthcare marketers. A lot of changes have occurred in healthcare marketing during the past 40 years – including the rise and fall of the salesforce, adoption of digital, and the advent of omnichannel marketing – and Med Ad News continues to highlight and analyze the trends.

February 13, 2022/by Christiane Truelove

2022: Digital sleuthing — New and Better Ways to Find KOLs/DOLs

Brands, Doctors, Facebook, February 2022, HCPs, Healthcare Communications Agencies, Instagram, Issue Archives, LinkedIn, Marketing & Advertising, Pharma, Social media, Software, Surveys, Twitter

Read Roberts, director of Key Opinion Leaders (KOL) data solutions at PRECISIONscientia, believes 2022 will see social media platforms as the new method for handling pharma medical education and peer-to-peer communications. So pharma must embrace a new type of digital sleuthing to find KOLs and Digital Opinion Leaders (DOLs), but they must do so carefully and think how to mitigate many risks in this highly regulated market, according to Roberts.

February 8, 2022/by Andrew Humphreys

Influencers, Ivermectin, and the Informational Divide: Pharma’s Big Opportunity to Grow a More Sustainable Attention Economy

Antiparasitics, Consumer Brands, Facebook, Healthcare Marketers, Healthcare Marketing, Influencer Marketing, Ivermectin, Marketing & Advertising, Twitter, White House

As global corporations reach deeper into every part of our lives, marketing is evolving into something unrecognizable. According to Michael Farmer, in the Mad Men Era of the 1960s and 70s, your average creative agency was responsible for roughly 350 deliverables a year—whether they were print copy, radio scripts, or billboard headlines. Today? The average number of deliverables per creative per year is over 10,000.

October 4, 2021/by Andrew Humphreys

FDA Says “Stop It” to Self-Medicating for COVID-19 with Unapproved Treatments

Animal Health, Antiparasitics, CDC, Coronavirus Disease (COVID-19) Pandemic, FDA, Ivermectin, Mississippi, Self-Medicating, Twitter, United States

“You are not a horse. You are not a cow. Seriously, y’all. Stop it.” This is the Food and Drug Administration’s (FDA) tweeted advice to Americans seeking out alternative, unapproved treatments for Covid-19.

August 23, 2021/by Andrew Humphreys

Facebook removes dozens of vaccine misinformation ‘superspreaders’

Business, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVID-19 misinformation, Facebook, Google, Instagram, Social media, Twitter, White House, YouTube

Facebook Inc. removed over three dozen pages spreading misinformation about Covid-19 vaccines, after the White House called on social media firms to tighten controls on pandemic-related facts shared on their platforms.

August 18, 2021/by Andrew Humphreys

U.S. states say Facebook, Twitter must do more to stop Covid-19 anti-vaxxers

Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Facebook, Social media, Twitter, United States, YouTube

Attorneys general for 12 U.S. states on March 24 accused Facebook Inc. and Twitter Inc. of doing too little to stop people from using their platforms to spread false information that coronavirus vaccines are unsafe.

March 24, 2021/by Andrew Humphreys

Global ‘PsoriasIS NOT CONTAGIOUS’ mask campaign for World Psoriasis Day

Campaigns, Coronavirus Disease (COVID-19) Pandemic, Healthcare Communications Agencies, Instagram, Marketing & Advertising, Masks, Pro bono campaigns, Psoriasis, TikTok, Twitter

Fishawack Health launched a pro bono campaign on World Psoriasis Day to raise awareness that psoriasis is not a contagious or unhygienic condition and to help lessen the stigma, discrimination, and exclusion of the 125 million people living with the skin condition globally.

October 29, 2020/by Andrew Humphreys

W2O Expands Symplur Data and Analytics Platform to Deepen Connections with Physicians

Analytics, Behavioral Insights, Business, Consumers, Coronavirus Disease (COVID-19) Pandemic, Data, Healthcare Providers, Life Sciences, Physicians, Social media, Strategy, Twitter, Webinars

W2O announced two new products available through Symplur, the company’s social media analytics platform dedicated exclusively to the healthcare industry.

October 29, 2020/by Andrew Humphreys

Dudnyk Launches Video Series Showcasing the Mysteries of Agency Life

Ad agency blogging, Facebook, Healthcare Communications Agencies, Instagram, LinkedIn, Marketing & Advertising, Social media, Twitter, Videos

In an expression of solidarity with other agencies across the world, Dudnyk released a three-part video campaign demonstrating the difficulties family members have in accurately describing what goes on at an agency.

April 30, 2020/by Administrator